Active	Status	Sponsor type	Region	Phase	Filter
13 Active 8 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

13 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Carson, Richard
NCT06303921: Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503	Recruiting	1	70	US	11C-M503 PET, Brain MRI, Amyloid PET, Neurological assessments	University of Pennsylvania	Tauopathies	02/29	02/29
Esterlis, Irina
NCT06705348: Social Disconnection Study	Recruiting	N/A	100	US		Yale University	Social Disconnection	02/28	02/28
NCT02734602: Imaging SV2A in Mood Disorders	Recruiting	N/A	130	US	Ketamine, Ket	Yale University, VA Office of Research and Development	Major Depressive Disorder, Post-Traumatic Stress Disorder	01/27	03/27
NCT03898297: Imaging mGluR5 and Synaptic Density in Psychiatric Disorders	Active, not recruiting	N/A	90	US	[18F]FPEB, [11C]APP311, [11C]UCB-J	Yale University, National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA)	Major Depressive Disorder, Bipolar Disorder, Healthy	04/25	04/25
NCT02727972: Examination of Glutamate and mGluR5 in Psychiatric Disorders	Active, not recruiting	N/A	180	US	Cognitive Testing, MRI, Magnetic Resonance Imaging, PET, Positron Emission Tomography	Yale University, VA Office of Research and Development	Major Depressive Disorder, Post-Traumatic Stress Disorder, Bipolar Disorder	08/25	08/25
O'Grady, Sarah
NCT03898297: Imaging mGluR5 and Synaptic Density in Psychiatric Disorders	Active, not recruiting	N/A	90	US	[18F]FPEB, [11C]APP311, [11C]UCB-J	Yale University, National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA)	Major Depressive Disorder, Bipolar Disorder, Healthy	04/25	04/25
Aboian, Mariam
NCT05655312: MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma	Recruiting	1/2	264	US	[203Pb]VMT01, [212Pb]VMT01, Nivolumab	Perspective Therapeutics	Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV, Mucosal Melanoma, Melanoma Stage III	12/27	12/29
NCT05408871: Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases	Terminated	1	7	US	adnectin 18F-BMS-986192 Head and Neck Cancer, [18F]PDL192, adnectin 18F-BMS-986192 Brain Metastases	Yale University, National Cancer Institute (NCI)	Cancer Head Neck, Metastatic Cancer, Metastatic Lung Cancer	01/24	01/24
NCT05553041: 18F-Fluciclovine PET-MRI in High-grade Glioma	Recruiting	1	30	US	18F-Fluciclovine PET-MRI, Axumin	Children's Hospital of Philadelphia, Blue Earth Diagnostics, Dragon Master Foundation	Glioma, High Grade Glioma, Glioma, Malignant, Glioma Intracranial, Diffuse Glioma	12/25	12/26
Matuskey, David
app311_med, NCT05418608: Novel in Vivo Synaptic Imaging in Experienced Meditators	Completed	1	20	US	Radiotracer, [11C]APP311, [11C]UCB-J	Yale University, National Center for Complementary and Integrative Health (NCCIH)	Behavior, Health	04/24	04/24
emo_to2, NCT06014385: PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor	Not yet recruiting	1	6	US	Scopolamine, [11C]EMO ([11C]LSN3172176)	Yale University, Janssen Scientific Affairs, LLC	Muscarinic Receptor Occupancy	07/25	07/25
Henry, Shannan
NCT06303921: Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503	Recruiting	1	70	US	11C-M503 PET, Brain MRI, Amyloid PET, Neurological assessments	University of Pennsylvania	Tauopathies	02/29	02/29
app311_med, NCT05418608: Novel in Vivo Synaptic Imaging in Experienced Meditators	Completed	1	20	US	Radiotracer, [11C]APP311, [11C]UCB-J	Yale University, National Center for Complementary and Integrative Health (NCCIH)	Behavior, Health	04/24	04/24